Pictured at left is Dr. Ruben Mesa, Mayo Clinic, our Scientific Advisor.
Dr. Mesa was one of the featured speakers at the San Mateo Patient Education Symposium held in May 2014. You can watch videos of all speakers at this event.
- View slides from the featured speakers of the Tampa Bay Area Symposium held in April 2014.
- You can watch video of all of the featured speakers at our Washington D.C Symposium held in Jan. 2014 .
- Information from our featured speakers at our recent Cleveland, Ohio Symposium will be available soon.
Clinical Trial Updates and News:
Get the latest news on MPN research, clinical trials, treatments, education, and advocacy.
- ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia
- PRM-151 therapy well tolerated in patients with advanced myelofibrosis
- Jakafi® Appears Effective in the Treatment of Essential Thrombocythemia
- Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: The missing piece in the puzzle of their increased cardiovascular risk?
- Dana-Farber, Brigham and Women’s Develop NGS Panel for Rapid Diagnosis of Hematologic Cancers
Patient & Caregiver Support
Join with other patients to learn more about your disease and treatment options through an in-person or online support group. Many major cities throughout the United States and internationally host regular meetings. Contact Ann Brazeau if you are interested in establishing a new Support Group for your area : 517.899.6889 email@example.com Learn More
Science Advisor: Ruben Mesa
Our scientific advisor is Dr. Ruben Mesa of the Mayo Clinic. Read his latest update: MPN Highlights from the American Society of Hematology
Free Patient Info Pack
Give us your address and we’ll send you a free informational package in the mail. Your contact information will be kept strictly confidential. Sign Up Now
What is a myeloproliferative neoplasm? MPNs are a group of rare blood cancers that overproduce blood cells in the bone marrow, and are caused by genetic mutations in the blood stem cells:
- Myelofibrosis is a rare bone marrow cancer. Bone marrow cells that produce blood cells develop and function abnormally resulting in fibrous scar tissue formation.
- Polycythemia Vera is a disorder in which the bone marrow makes too many red blood cells. It may also result in the production of too many other types of blood cells – white blood cells and platelets.
- Essential Thrombocythemia causes the body to produce too many blood platelets-thrombocytes. It can cause abnormal clotting or bleeding. The bone marrow makes too many platelet-forming cells or megakaryocytes, which release platelets into your blood.